Dr. Ashkan Lashkari, MD

Dr. Lashkari practices at Valley Surgical Center LLC in West Hills, California.

Dr. Lashkari's NPI, 1528284627, was assigned on April 17, 2007. Dr. Lashkari graduated from David Geffen School of Medicine at UCLA in 2003. Dr. Lashkari holds California license A90916.

Dr. Lashkari's primary practice is Valley Surgical Center LLC, at 7320 N Woodlake Ave, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 610-3966.

Dr. Lashkari's primary practice is Valley Surgical Center LLC in West Hills, California. Dr. Lashkari is also affiliated with UCLA West Valley Medical Center. The medical group on file is Wellness Oncology & Hematology. Dmand AI also links Dr. Lashkari to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lashkari practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lashkari's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lashkari is board certified in hematology by the American Board of Internal Medicine. Dr. Lashkari is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Lashkari treats.

CMS data shows 86,484 Medicare services from Dr. Lashkari across 57 procedure codes in 2024, for 826 Medicare patients. Medicare paid $1,523,426 for them.

CMS counts 826 Medicare patients who saw Dr. Lashkari in 2024. The largest group is 75 to 84, with 329 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lashkari's median patient age at 72, with 56% women.

In 2024, Dr. Lashkari wrote 2,260 Medicare Part D claims for 285 patients. 68% of them were for generic drugs. CMS names the drug for 1,716 of them, across 70 drugs with 11 or more claims each, at $6,803,429 in total drug cost. In 2023, CMS named 1,452 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lashkari for performance year 2024, reported as part of a group. Dr. Lashkari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lashkari as offering telehealth.

Dmand AI links 4 papers to Dr. Lashkari in 2011. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Lashkari's most frequent co-authors are George Somlo, MD, Zaid Al-Kadhimi, MD and Helen Chen, MD.

Dmand AI links Dr. Lashkari to 5 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Leukemia, Myelomonocytic, Chronic.

CMS Open Payments shows 515 general payments to Dr. Lashkari from 69 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Bristol-Myers Squibb Company paid the most, $27,447.

Dr. Lashkari graduated from David Geffen School of Medicine at UCLA in 2003.

Dr. Lashkari is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.